Connect Sign InAdvancements in HER2-Directed Therapy for Breast Cancer
HER2-positive metastatic breast cancer survival has improved significantly with many novel directed therapies under investigation. HER2-low expression can respond to directed therapy; however, more accurate testing is still needed.
Dr. Mei Wei is a medical oncologist and assistant professor (clinical) at the Huntsman Cancer Institute, University of Utah. Dr. Wei received her medical degree from Anhui Medical University. She completed residencies in gynecological oncology and radiation oncology Sun Yat-sen University Cancer Center, a postdoctoral research fellowship in cancer epidemiology at the University of Utah School of Medicine, an internship in internal medicine at the University of Nevada, Reno School of Medicine, a residency in internal medicine at the University of Utah School of Medicine, and a fellowship in hematology/oncology at the University of Utah School of Medicine. Dr. Wei focuses her practice on breast oncology with clinical research interests in clinical trials and breast cancer outcomes.
